These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 24593273

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.
    Ann Intern Med; 2003 May 06; 138(9):705-13. PubMed ID: 12729424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH, Kan LP, Lin HA, Chang FY, Wang NC, Lin TY, Chao TY, Kao WY, Ho CL, Chen YC, Dai MS, Chang PY, Wu YY, Lin JC.
    J Microbiol Immunol Infect; 2016 Aug 06; 49(4):531-8. PubMed ID: 25440977
    [Abstract] [Full Text] [Related]

  • 7. Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis.
    Liu Q, Lin R, Sun J, Xiao Y, Nie D, Zhang Y, Huang F, Fan Z, Zhou H, Jiang Q, Zhang F, Zhai X, Xu D, Wei Y, Song J, Li Y, Feng R.
    Biol Blood Marrow Transplant; 2014 Aug 06; 20(8):1198-203. PubMed ID: 24769013
    [Abstract] [Full Text] [Related]

  • 8. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L, Kuehlke O, Beilken A, Sander A, Linderkamp C, Schmid H, Seidemann K, Sykora KW, Schuster FR, Welte K.
    Pediatr Transplant; 2007 May 06; 11(3):261-6. PubMed ID: 17430480
    [Abstract] [Full Text] [Related]

  • 9. [Development of treatment adherence by jellification of itraconazole oral solution].
    Wada H, Tanabe S, Ichikawa K, Sano F, Kubo Y, Matsuhashi Y, Nakanishi H, Tasaka T, Sugihara T.
    Jpn J Antibiot; 2009 Feb 06; 62(1):17-25. PubMed ID: 19378767
    [Abstract] [Full Text] [Related]

  • 10. Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
    Gao X, Marks DI, Schlamm HT, Ji X, Stephens JM, Tarallo M.
    J Med Econ; 2013 Aug 06; 16(8):1061-70. PubMed ID: 23730943
    [Abstract] [Full Text] [Related]

  • 11. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul 06; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 12. Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial.
    Wan L, Zhang Y, Lai Y, Jiang M, Song Y, Zhou J, Zhang Z, Duan X, Fu Y, Liao L, Wang C.
    J Clin Oncol; 2015 Dec 01; 33(34):3999-4006. PubMed ID: 26392095
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation].
    Shi JM, Wang C, Zhou YH, Yu K, Du X, Luo Y, Cai Z, He JS, Ye XJ, Zhang J, Xie WZ, Huang H.
    Zhonghua Xue Ye Xue Za Zhi; 2013 May 01; 34(5):413-6. PubMed ID: 23688752
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation].
    Ota S, Wada A, Kosugi M, Matsuoka S, Asanuma S, Fujii S, Noguchi S, Nakata M, Imai K, Hirano T, Kobayashi N, Ogasawara M, Kiyama Y, Kasai M.
    Rinsho Ketsueki; 2010 Jan 01; 51(1):63-8. PubMed ID: 20134142
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
    Choi JK, Cho SY, Yoon SS, Moon JH, Kim SH, Lee JH, Kim JS, Cheong JW, Jang JH, Seo BJ, Kim YJ, Lee HJ, Lee J, Lee JW, Lee DG.
    Biol Blood Marrow Transplant; 2017 Oct 01; 23(10):1773-1779. PubMed ID: 28668492
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.